Viral replication impedes the efficacy of a targeted therapy against virus-induced lymphomas

April 3, 2012, University of Helsinki

Kaposi's sarcoma herpesvirus (KSHV) is a human tumor virus and an etiological agent for Kaposi's sarcoma and primary effusion lymphoma (PEL). PELs are aggressive lymphomas with reported median survival time shorter than six months after diagnosis.

Researchers at the University of Helsinki discovered that spontaneous induction of lytic replication in tumors drastically attenuated the p53-dependent apoptotic response not only to a targeted therapy (Nutlin-3) but also to genotoxic anti-cancer agents.

The findings by the research groups of Päivi Ojala (Institute of Biotechnology & Research Programs Unit) and Pirjo Laakkonen (Research Programs Unit, Univ. of Helsinki) provide valuable in-depth knowledge on the use of reactivation of p53 as a highly selective treatment modality for the virally-induced lymphoma. The project involves scientists from the Genome-Scale Biology and Molecular Cancer Biology Research Programs.

TP53 gene encodes a transcription factor (p53) that plays a central role in protecting cells from development by inducing cell-cycle arrest or apoptosis via a complex signal transduction network referred to as the p53 pathway. TP53 gene is mutated or deleted in 50% of all malignant tumors. A potent strategy for restoration of p53 function is based on the inhibition of the interaction of p53 with its negative regulator MDM2 via a selective small-molecule inhibitor of the p53–MDM2 interaction, the Nutlin-3.

PEL is a non-Hodgkin type latently infected with KSHV, and it manifests as an effusion malignancy in Kaposi's sarcoma patients. There are no current therapies effective against the aggressive KSHV-induced PEL. KSHV displays two patterns of infection: latent and lytic phase. During latency, only a restricted set of viral genes is expressed. The KSHV genome encodes several homologues of cellular proteins, which engage cellular signaling pathways, govern cell proliferation and modulate apoptosis.

Majority of the PELs appear to have an intact TP53 gene suggesting that genetic alterations are not selected for during PEL tumorigenesis. Earlier report from the same researchers showed that Nutlin-3 selectively induces massive apoptosis in PEL cells leading to efficient anti-tumor activity in a subcutaneous xenograft model for PEL (Sarek et al. 2007, Journal of Clinical Investigation).

Here they report viral lytic replication as a factor, which can hamper the otherwise efficient apoptotic response of p53 restoration in vivo. Spontaneous induction of viral lytic replication in the tumors drastically attenuated the Nutlin-3-induced p53-dependent apoptotic response. Attenuation of the cell death response in the lytic PEL cells was not restricted to reactivation by the MDM2 inhibitor Nutlin-3, but was also observed upon induction of apoptosis by genotoxic agents. Importantly, the undesired resistance was overcome and the sensitivity of cells to Nutlin-3-induced apoptosis was restored by inhibition of viral replication.

The study was published yesterday in the Oncogene.

Explore further: Molecule Nutlin-3a activates a signal inducing cell death and senescence in primary brain tumors

More information: Sarek, S., Ma, L., Enbäck, J., Järviluoma, A., Moreau, P., Haas, J., Gessain, A.,. Koskinen, P.J., Laakkonen, P. and Ojala, P.M. Kaposi's sarcoma herpesvirus lytic replication compromises apoptotic response to p53 reactivation in virus-induced lymphomas. Oncogene, April 2012, Advanced online publication.

Sarek G., Kurki S., Enbäck J., Iotzova G., Haas J., Laakkonen P., Laiho M., and Ojala P.M. 2007. Reactivation of the p53 Pathway as a Novel Treatment Modality for KSHV-induced Lymphomas, J. Clin. Invest. 117(4):1019-28.

Related Stories

Molecule Nutlin-3a activates a signal inducing cell death and senescence in primary brain tumors

April 20, 2011
Researchers of Apoptosis and Cancer Group of the Bellvitge Biomedical Research Institute (IDIBELL) have found that a small molecule, Nutlin-3a, an antagonist of MDM2 protein, stimulates the signalling pathway of another protein, ...

KS-herpesvirus induces reprogramming of lymphatic endothelial cells to invasive mesenchymal cells

December 14, 2011
Kaposi's sarcoma herpesvirus (KSHV) is an etiological agent for Kaposi's sarcoma and two other rare lymphoproliferative malignancies, and it is the most common cancer in HIV-infected untreated individuals. Researchers at ...

Recommended for you

How cancer metastasis happens: Researchers reveal a key mechanism

January 18, 2018
Cancer metastasis, the migration of cells from a primary tumor to form distant tumors in the body, can be triggered by a chronic leakage of DNA within tumor cells, according to a team led by Weill Cornell Medicine and Memorial ...

Modular gene enhancer promotes leukemia and regulates effectiveness of chemotherapy

January 18, 2018
Every day, billions of new blood cells are generated in the bone marrow. The gene Myc is known to play an important role in this process, and is also known to play a role in cancer. Scientists from the German Cancer Research ...

These foods may up your odds for colon cancer

January 18, 2018
(HealthDay)—Chowing down on red meat, white bread and sugar-laden drinks might increase your long-term risk of colon cancer, a new study suggests.

The pill lowers ovarian cancer risk, even for smokers

January 18, 2018
(HealthDay)—It's known that use of the birth control pill is tied to lower odds for ovarian cancer, but new research shows the benefit extends to smokers or women who are obese.

Researchers develop swallowable test to detect pre-cancerous Barrett's esophagus

January 17, 2018
Investigators at Case Western Reserve University School of Medicine and University Hospitals Cleveland Medical Center have developed a simple, swallowable test for early detection of Barrett's esophagus that offers promise ...

Scientists zoom in to watch DNA code being read

January 17, 2018
Scientists have unveiled incredible images of how the DNA code is read and interpreted—revealing new detail about one of the fundamental processes of life.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.